Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.

MLA

Filì, Maria, et al. “Ruthenium-106 versus Iodine-125 Plaque Brachytherapy of 571 Choroidal Melanomas with a Thickness of ≥5.5 Mm.” British Journal of Ophthalmology, vol. 104, no. 1, Jan. 2020, pp. 26–32. EBSCOhost, https://doi.org/10.1136/bjophthalmol-2018-313419.

APA

Filì, M., Trocme, E., Bergman, L., Ong See, T. R., André, H., Bartuma, K., Girnita, L., Eriksson, C. A., Seregard, S., & Stålhammar, G. (2020). Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm. British Journal of Ophthalmology, 104(1), 26–32. https://doi.org/10.1136/bjophthalmol-2018-313419

Chicago

Filì, Maria, Eric Trocme, Louise Bergman, Thonnie Rose Ong See, Helder André, Katarina Bartuma, Leonard Girnita, Charlotta All Eriksson, Stefan Seregard, and Gustav Stålhammar. 2020. “Ruthenium-106 versus Iodine-125 Plaque Brachytherapy of 571 Choroidal Melanomas with a Thickness of ≥5.5 Mm.” British Journal of Ophthalmology 104 (1): 26–32. doi:10.1136/bjophthalmol-2018-313419.